Mari Galloway

The respondents, facing multiple class actions related to the manufacture and distribution of opioids over a 20-year period, sought coverage for defence costs from their successive primary and excess liability insurers.

The application judge allowed the respondents to select a single primary insurer to fund the entire defence, permitted the exhaustion of self-insured retentions (SIRs) using payments from other insurers, granted relief from forfeiture for pre-tender defence costs, and required insurers to sign a Defence Reporting Agreement (DRA) to receive privileged defence information.

The Court of Appeal allowed the insurers' appeals in part, holding that defence costs must be allocated on a pro rata time-on-risk basis, that the insureds must exhaust each applicable SIR before an insurer's duty to defend is triggered, and that relief from forfeiture was unavailable for pre-tender costs.

The Court upheld the DRA requirement for insurers seeking to associate in the defence to mitigate reasonable apprehensions of conflict of interest.

The Ontario Securities Commission (OSC) brought a motion seeking an order for the issuance of Letters of Request in Commissions under section 152 of the Securities Act.

The OSC required evidence from two individuals, one residing in British Columbia and one in Massachusetts, USA, for a proceeding before the Capital Markets Tribunal concerning Bridging Finance Inc. and its respondents.

The respondents did not oppose the motion.

The court granted the order, finding that the proposed witnesses had relevant evidence and that the Letters of Request and Commissions accorded with Rule 34.07(2) of the Rules of Civil Procedure.

The plaintiff, Zorida Chrysostom, brought a medical negligence action against the defendant physicians and health system, alleging failure to diagnose cauda equina syndrome during her emergency department visit.

The court found that two defendant physicians, Dr. Mann and Dr. Kempenaar, fell below the standard of care by failing to adequately inquire about and document saddle anaesthesia, a cardinal symptom of cauda equina syndrome.

The court also concluded, on a balance of probabilities, that the plaintiff did suffer from cauda equina syndrome at the time of the initial visit, which would have necessitated earlier emergency surgery and improved her outcome.

Damages were agreed upon, and the judgment focused on liability.

The Applicants sought costs following a partial success in an application concerning insurance coverage, specifically the duty to defend and equitable allocation among insurers.

The court awarded full indemnity costs to the Applicants against AIG and Royal & Sun Alliance Insurance Company of Canada (RSA) for the duty to defend issue, finding the Applicants overwhelmingly successful on that point.

Costs related to the exhaustion of self-insured retentions (SIRs)/deductibles were deferred to a future trial of the issue, as neither party fully succeeded.

Zurich Insurance Company Ltd. was ordered to pay reduced costs due to its partial success on a specific "Single Retention Endorsement" interpretation.

The representative plaintiff sought approval of a class action settlement regarding 'defeat devices' in Mercedes Benz BlueTEC diesel vehicles.

The settlement, valued at approximately $530 million, included no-charge emission modifications, extended warranties, and cash payments.

The court approved the settlement as fair and reasonable, noting the risks of further litigation.

The court also approved $14 million in legal fees to be paid by the defendants and a $10,000 honorarium for the representative plaintiff.